Bohen Sean 4/A
4/A · Olema Pharmaceuticals, Inc. · Filed Sep 23, 2022
Insider Transaction Report
Form 4/AAmended
Bohen Sean
DirectorPRESIDENT AND CEO
Transactions
- Purchase
Common Stock
2022-09-21+20,000→ 74,279 total
Footnotes (3)
- [F1]This amendment is being filed solely to correct the transaction code in column 3 of Table I from code "A" to code "P".
- [F2]The weighted average purchase price for the transaction reported was $3.16, and the range of prices were between $3.15 and $3.19. Upon request from the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased at each separate price will be provided.
- [F3]Includes 5 shares acquired under the issuer's Employee Stock Purchase Plan.